PRESS CONFERENCE SOCMA and EFCG To Announce Joint Position Paper
Press briefing on a position paper by SOCMA and EFCG to discuss GMP compliance inspections of foreign active pharmaceutical ingredient manufacturing facilities by the U.S. FDA and corresponding E.U. Agencies. The paper addresses patient risk, national security and economic level playing field.

/Pharmaceutical News Articles/ - October 04, 2006 - Speakers: Joe Acker - President of SOCMA, speaking on behalf of the Bulk Pharmaceutical Task Force

Guy Villax - CEO of Hovione, speaking as Chairman of the EFCG Pharmaceuticals Business Committee


Tuesday, October 3, 2006
16h10 - 16h45 (Paris Time)

Press Briefing Room
Hall 6 - Room 6C11
CPhI - Paris, France
Parc d'Expositions PARIS-NORD Villepinte
BP 60004, 95970 Roissy - CDG Cedex


Gregory Minchak
Manager, Public Relations & Communications
(202)721-4182
minchakg@socma.org

Press Release Contact Information:

Gregory Minchak
Synthetic Organic Chemical Manuf
Manager, Communication
Washington, DC
USA 20036
Voice: 202-721-4128
Website: Visit Our Website